449 related articles for article (PubMed ID: 27515856)
1. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
[TBL] [Abstract][Full Text] [Related]
2. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
Doyle LA; Fletcher CD; Hornick JL
Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
[TBL] [Abstract][Full Text] [Related]
4. Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma with a novel pattern of SERPINE1-FOSB fusion detected by RT-PCR--report of a case.
Ide YH; Tsukamoto Y; Ito T; Watanabe T; Nakagawa N; Haneda T; Nagai M; Yamanishi K; Hirota S
Pathol Res Pract; 2015 May; 211(5):415-20. PubMed ID: 25749627
[TBL] [Abstract][Full Text] [Related]
5. CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma.
Jung H; Kim HN; Jang Y; Park CK; Ha SY
In Vivo; 2019; 33(6):2293-2297. PubMed ID: 31662570
[TBL] [Abstract][Full Text] [Related]
6. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
Yusıflı Z; Kösemehmetoğlu K
Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239
[TBL] [Abstract][Full Text] [Related]
7. Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study.
Pradhan D; Schoedel K; McGough RL; Ranganathan S; Rao UNM
Hum Pathol; 2018 Jan; 71():126-134. PubMed ID: 29104110
[TBL] [Abstract][Full Text] [Related]
8. A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature.
Ge Y; Lin X; Zhang F; Xu F; Luo L; Huang W; Liu Z; Liu Y; Li Z
Diagn Pathol; 2019 Jul; 14(1):79. PubMed ID: 31311568
[TBL] [Abstract][Full Text] [Related]
9. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract][Full Text] [Related]
10. FOSB immunoreactivity in endothelia of epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia).
Ortins-Pina A; Llamas-Velasco M; Turpin S; Soares-de-Almeida L; Filipe P; Kutzner H
J Cutan Pathol; 2018 Jun; 45(6):395-402. PubMed ID: 29527734
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and molecular features of vascular tumors in a series of 118 cases.
Wei H; Zhen T; Tuo Y; Li H; Liang J; Chen S; Shi H; Han A
Am J Transl Res; 2022; 14(5):2939-2951. PubMed ID: 35702134
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
Anderson WJ; Fletcher CDM; Hornick JL
Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
[TBL] [Abstract][Full Text] [Related]
13. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions.
Anderson T; Zhang L; Hameed M; Rusch V; Travis WD; Antonescu CR
Am J Surg Pathol; 2015 Jan; 39(1):132-9. PubMed ID: 25353289
[TBL] [Abstract][Full Text] [Related]
14. Primary pseudomyogenic hemangioendothelioma of bone: case report and review of the literature.
Squillaci S; Pitino A; Spairani C; Rassu PC; Chiapuzzo E; Kutzner H
Pathologica; 2018 Sep; 110(2):96-101. PubMed ID: 30546145
[TBL] [Abstract][Full Text] [Related]
15. A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone.
Bridge JA; Sumegi J; Royce T; Baker M; Linos K
Genes Chromosomes Cancer; 2021 Jan; 60(1):38-42. PubMed ID: 32749039
[TBL] [Abstract][Full Text] [Related]
16. [Atypical epithelioid hemangioendothelioma: a clinicopathological analysis of eight cases].
Gong QX; Fan QH; Ding Y; Xiao QX; Wang QY; Tang JL; Song QY; Wang B
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):620-625. PubMed ID: 31422593
[No Abstract] [Full Text] [Related]
17. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
18. Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case.
Fan C; Yang L; Lin X; Wang E
Diagn Pathol; 2015 Aug; 10():150. PubMed ID: 26315812
[TBL] [Abstract][Full Text] [Related]
19. A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.
Walther C; Tayebwa J; Lilljebjörn H; Magnusson L; Nilsson J; von Steyern FV; Øra I; Domanski HA; Fioretos T; Nord KH; Fletcher CD; Mertens F
J Pathol; 2014 Apr; 232(5):534-40. PubMed ID: 24374978
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of pseudomyogenic hemangioendothelioma.
Yang N; Huang Y; Yang P; Yan W; Zhang S; Li N; Feng Z
Diagn Pathol; 2023 Feb; 18(1):25. PubMed ID: 36803395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]